Abstract
Carotid cavernous fistulas (CCF) are complex lesions involving the abnormal shunting of arterial blood into the cavernous sinus. There are two distinct types: one is a direct communication between the internal carotid artery and the cavernous sinus, while the other is a dural shunt involving meningeal branches of the external and/or internal carotid arteries. Resulting patient symptoms as well as potential complications is determined primarily by the degree of arteriovenous shunting as well as the direction of venous outflow from the cavernous sinus. Catheter angiography remains the gold standard imaging evaluation of CCFs, although both MR and CT angiography can be used to screen patients in whom the diagnosis is suspected. Current treatment for these lesions consists primarily of conservative management and endovascular embolization. The latter can be performed via transarterial and/or transvenous approaches, using various materials such as detachable balloons, coils, and liquid embolic agents. A multidisciplinary approach, including neurointerventionalists, neurosurgeons, and ophthalmologists, is often required to achieve the best outcomes for patients.
Access provided by Autonomous University of Puebla. Download reference work entry PDF
Similar content being viewed by others
Keywords
1 Introduction
A carotid cavernous fistula (CCF) is an abnormal arteriovenous shunt involving the cavernous sinus [1, 2]. The term actually applies to two distinct lesions, which vary in their etiology, potential clinical presentations, treatment, and outcomes. The first is a direct CCF, which consists of a tear in the cavernous segment of the internal carotid artery (ICA) with direct shunting of arterial blood into the sinus [2]. The second is an indirect CCF, which represents a dural arteriovenous fistula involving the cavernous sinus wall, which is fed by meningeal arterial branches that normally supply this region [1, 2]. Despite their differences, both lesions involve shunting of arterial blood into the normally low-pressure cavernous sinus, with resulting symptoms and complications determined primarily by the degree and route of venous drainage from the diseased sinus [3, 4]. The following chapter explores the characteristics of both types of CCF, highlighting their differences as well as similarities.
Types of Carotid Cavernous Fistula
-
Direct fistulas: A direct fistulous communication between the cavernous segment of the internal carotid artery and the surrounding cavernous sinus
-
Indirect fistulas: A dural arteriovenous fistula involving meningeal branches of the internal and external carotid arteries that normally supply the region of the cavernous sinus
2 Anatomy of the Cavernous Sinus and Cavernous Segment of the Internal Carotid Artery
Cavernous Sinus: The cavernous sinus is a contiguous network of trabeculated venous sinusoids surrounded by dura matter that is located centrally in the skull base adjacent to the pituitary sella and sphenoid sinus [5–7]. It contains both the cavernous segment of the ICA and cranial nerves III, IV, V1, V2, and VI [5–7]. Cranial nerves III, IV, V1, and V2 run in the lateral wall of the sinus, while VI is located within the sinus itself. The cavernous sinus normally receives venous blood from the ipsilateral orbit and brain, including the superior ophthalmic, inferior ophthalmic, superficial middle cerebral, and deep middle cerebral veins, as well as the sphenoparietal sinus [4, 8]. Venous outflow from the cavernous sinus is via superior and inferior petrosal sinuses to the transverse sinus and internal jugular vein respectively, as well as inferiorly via the pterygoid venous plexus as well as emissary veins associated with the foramina ovale and rotundum [4, 8]. Finally, the cavernous sinuses are interconnected via a venous network centered around the hypophysis, the so-called circular sinus [2, 9]. Although the circular sinus generally consists of a larger anterior and smaller posterior limbs, either may be absent or hypoplastic in a particular patient.
Contents of the Cavernous Sinus
-
Cavernous segment of the internal carotid artery
-
Cranial nerve VI
-
Cranial nerves III, IV, V1, and V2 in the lateral wall of the sinus
Normal Hemodynamics of the Cavernous Sinus
-
Venous inflow
-
Orbital veins: superior, inferior ophthalmic, and central retinal
-
Superficial and deep middle cerebral veins
-
Sphenoparietal sinus
-
-
Venous outflow
-
Superior petrosal sinus
-
Drains to transverse sinus
-
-
Inferior petrosal sinus
-
Drains to internal jugular vein
-
-
Pterygoid venous plexus
-
Emissary veins around foramina ovale and rotundum
-
-
Intercavernous flow
-
Circular sinus
-
Internal Carotid Artery: The ICA ascends vertically in the skull base from the foramen lacerum into the cavernous sinus, before turning anteriorly into a horizontal segment approximately 2 cm in length [6]. The artery then ascends superiorly in a second vertical segment, extending along the medial aspect of the anterior clinoid process before exiting the sinus. The cavernous segment of the ICA can be divided into five segments, as detailed by Debrun et al. [10]. Going from caudal to cranial, these include the posterior ascending segment, junction of posterior ascending segment and horizontal segment, horizontal segment, junction of the horizontal segment and anterior ascending segment, and ascending segment [10]. Although any segment of the cavernous ICA may be involved by a direct CCF, the horizontal portion is the most common site of fistulization [10].
The cavernous segment of the ICA has two main branches that, along with distal branches of the internal maxillary artery from the external carotid, supply the dura surrounding the cavernous sinus as well as the nearby cranial nerves [2, 5, 11]. Small anastomoses between these branches of the external and internal carotid arteries are normally present in the surrounding dura and are responsible for the dural arteriovenous shunts found in indirect CCF [1, 5, 11]. The first is the meningohypophyseal trunk, present in 100 % of patients, which arises from the apex of the proximal curve of the vessel in the cavernous sinus [6]. This artery in turn has three main branches: the artery to the tentorium (Bernasconi-Cassonari), the dorsal meningeal artery to the clivus, as well as the inferior hypophyseal artery [5]. The second branch of the cavernous ICA is the inferolateral trunk (ILT), found in 84 % of patients, which originates from the distal horizontal segment of the vessel and is the most common branch to be involved by an indirect CCF [5, 6]. The ILT also has three main branches: superior or tentorial, anterior, and posterior branches, which supply dura as well as cranial nerves III, IV, V1, V2, and VI in and around the cavernous sinus and orbit [5]. Finally, the cavernous ICA may also give rise to McConnell’s capsular arteries, although these vessels are inconstantly present [6].
Branches of the Cavernous Internal Carotid Artery
-
Meningohypophyseal trunk
-
Artery to the tentorium (Bernasconi-Cassonari)
-
Dorsal meningeal artery
-
Inferior hypophyseal artery
-
-
Inferolateral trunk
-
Superior or tentorial branch
-
Anterior branch
-
Posterior branch
-
-
Capsular arteries
3 Pathophysiology
All CCFs demonstrate the same basic pathophysiologic mechanism of abnormal shunting of arterial blood into the normally low-pressure venous cavernous sinus. The resulting increase in pressure and volume results in reversal of blood flow in venous structures that normally drain the cavernous sinus, including the superior and inferior ophthalmic veins as well as the superior and inferior petrosal sinuses [4]. The resulting signs and symptoms associated with a CCF are determined both by the degree of arteriovenous shunting and the route of venous drainage from the cavernous sinus [3, 4]. The latter is determined by the location of the arteriovenous shunt, the presence of thrombus in the involved sinus, as well as stenosis or thrombosis of potential venous drainage pathways [10]. If the hemodynamic changes associated with a CCF persist over a long period of time, the involved veins may become arterialized with thickened, hyalinized walls [1]. Other chronic changes include recruitment of capillary connections in the conjunctiva of the eye, which are called specific limbal loops [1].
There are various patterns of venous drainage from the cavernous sinus that can be encountered with a CCF, which have important implications for patient symptomatology as well as the risk of intracranial complications (Fig. 1) [4, 10, 12]. Anterior drainage is commonly present, with reflux of blood into the ipsilateral orbit via the superior and inferior ophthalmic veins, with subsequent drainage into angular and facial veins [1, 12]. An additional anterior drainage route consists of the sphenoparietal sinus running along the anterior middle cranial fossa [2]. Posterior drainage from the cavernous sinus into the inferior and superior petrosal sinuses is also often encountered, either alone or in combination with anterior as well as contralateral drainage via the circular sinus [2, 4, 10, 12]. It has been speculated that the majority, if not all, of low-flow indirect CCF originally drain posteriorly, with anterior drainage only commencing once the posterior pathway becomes obstructed, often due to thrombosis [12]. Finally, superior and inferior venous drainage from the cavernous sinus can proceed via the Sylvian vein and pterygoid venous plexus, respectively [4].
Potential Routes of CCF Venous Drainage
-
Anterior drainage via the orbital veins
-
Eventually draining into angular and facial veins
-
-
Posterior drainage
-
Superior and inferior petrosal sinuses
-
-
Contralateral drainage
-
Circular sinus
-
-
Superior drainage
-
Superficial middle cerebral vein
-
-
Inferior drainage
-
Pterygoid venous plexus & emissary veins
-
4 Classification
CCFs can be categorized using several criteria [5, 13]. These include classifications systems based on etiology (i.e., traumatic vs. spontaneous), hemodynamics (high-flow vs. low-flow shunts), as well as angiographic criteria [1, 5, 8, 13]. The latter was characterized by Barrow et al. [5] and is based on both the hemodynamics of the shunt as well as the arterial supply to the fistula as demonstrated on angiography [5].
Type A CCFs are high-flow direct shunts between the ICA and the cavernous sinus (Fig. 2). Type B CCFs are dural shunts between meningeal branches of the cavernous ICA (arising from the meningohypophyseal or ILT trunks) and the cavernous sinus (Fig. 3). Type C CCFs are dural shunts between external carotid meningeal branches and the cavernous sinus (Fig. 4). Finally, type D CCFs are dural shunts with arterial supply from meningeal branches of both the ICA and ECA (Fig. 5) [5]. Rarely, a direct fistula between the ophthalmic artery and an ophthalmic vein can present in a similar fashion to a CCF, a so-called orbital shunt [1] (Fig. 6; Table 1).
5 Etiology and Epidemiology
Direct Fistulas: Direct CCFs often result from blunt or penetrating trauma that results in a tear in the cavernous segment of the ICA, with resulting rapid arteriovenous shunting into the cavernous sinus [8, 10, 14]. These lesions are most commonly found in young males, presumably due to the increased prevalence of head trauma in this population [13–15]. Debrun et al. [10] found that the arterial tear in traumatic fistulas can vary in size anywhere from 1 to 5 mm, and rarely multiple rents may be present. Despite the high-flow arteriovenous shunting associated with direct fistulas, patients often present in a somewhat delayed fashion, anywhere from days to a few weeks following the inciting trauma [16]. The mechanism of vessel injury in many of these cases is likely a sudden increase in intraluminal arterial pressure associated with the traumatic event [17]. Penetrating trauma is another possible cause, as well as rarely arterial injury during skull base surgery [14–16, 18]. Finally, traumatic direct CCFs have been associated with fractures involving the skull base, with Liang et al. [16] in a retrospective review reporting an 8.3 % incidence of direct fistulas in patients with fractures involving the middle cranial fossa, particularly those with a transverse or oblique orientation.
Direct CCF fistulas can also be encountered in patients without a history of preceding trauma [8, 19]. These lesions are often encountered in middle-age women, but are not exclusive to this age group [20]. These spontaneous direct fistulas have several potential etiologies, the most common of which is rupture of a cavernous segment ICA aneurysm [18, 19]. Cavernous ICA aneurysms represent somewhere between 1.9 % and 9 % of all intracranial aneurysms, are more commonly associated with CCF development as opposed to subarachnoid hemorrhage, and give rise to roughly 20 % of direct CCFs [14, 19, 21]. In a retrospective review of all cavernous ICA aneurysms presenting to a single medical center, Kupersmith et al. [21] found that 13 of 193 lesions were associated with a CCF (6.7 %). However, it is important to remember that a predisposing cavernous aneurysm may not be identified following direct fistula formation due to the presence of high-flow arteriovenous shunting [22].
Etiologies of Direct Carotid Cavernous Fistulas
-
Traumatic
-
Blunt
-
Penetrating
-
Iatrogenic
-
-
Spontaneous
-
ICA aneurysm rupture
-
Collagen vascular disorders
-
Ehlers-Danlos type IV syndrome
-
Pseudoxanthoma elasticum
-
Fibromuscular dysplasia
-
-
Minor episode of trauma or valsalva
-
Coughing and sneezing
-
-
An additional cause of spontaneous direct CCFs includes various genetic syndromes that can weaken the arterial wall and predispose to rupture after minor trauma or episodes of valsalva, including coughing or sneezing [1, 18, 19]. Specific genetic conditions that can affect vascular wall structural integrity and have been associated with CCF include fibromuscular dysplasia, Ehlers-Danlos type IV syndrome, and pseudoxanthoma elasticum [23–25]. Finally, a direct CCF can be associated with a persistent trigeminal artery extending from the cavernous ICA to the basilar artery [22]. These so-called trigemino-cavernous fistulas may arise either from an inherent weakness in the aberrant vessel wall or due to aneurysm formation at the ICA-trigeminal artery branch point [22].
Indirect or Dural Fistulas: Indirect CCFs represent a subset of dural arteriovenous fistulas involving the cavernous sinus, which receive blood flow from meningeal branches of the internal and/or external carotid arteries that normally supply the cavernous sinus dura [2, 26]. These lesions most often occur spontaneously in postmenopausal women [15, 26, 27]. However, as is the case with direct CCFs, these lesions may present in all age groups, including children and infants, and can develop following minor trauma or episodes of valsalva [12]. Altogether, dural arteriovenous fistulas represent approximately 10–15 % of intracranial vascular malformations [28]. Potential arterial feeders to indirect CCFs include branches of the external carotid artery, such as the internal maxillary, middle meningeal, accessory meningeal, and ascending pharyngeal arteries, as well as internal carotid artery branches [26]. The latter include meningohypophyseal, capsular, inferolateral trunk arteries, as well as ethmoidal branches arising from the ophthalmic artery [26].
As is the case with dural arteriovenous fistulas found elsewhere in the intracranial compartment, the etiology of indirect CCF remains uncertain [12, 15]. One theory speculates that these fistulas may result from breakdown in small thin-walled dural arteries that normally cross the cavernous sinus [12]. Alternatively, venous thrombosis and/or elevated venous pressure may result in the opening of normally closed, small anastomotic channels in the dura [8, 12]. Risk factors for the development of these dural fistulas include atherosclerosis, hypertension, diabetes, sinusitis, pregnancy, and collagen vascular disease [8, 27, 29].
Etiology of Indirect Carotid Cavernous Fistulas
-
Uncertain, two possible mechanisms
-
Breakdown of small thin-walled dural arteries that transverse the cavernous sinus
-
Opening of small anastomotic dural channels
-
Venous sinus thrombosis
-
Elevated venous pressure
-
-
-
Risk factors
-
Atherosclerosis, diabetes, hypertension, and pregnancy
-
6 Clinical Presentations
The majority of symptomatic CCFs have anterior drainage via the ophthalmic veins, with resulting reflux of high-pressure arterial blood into the ipsilateral orbit [3, 12, 15]. This arteriovenous shunting results in orbito-ocular congestion and is responsible for the classic clinical triad associated with CCFs, namely, pulsatile exophthalmos, orbital bruit, and chemosis of the ipsilateral globe [1, 3, 4, 14, 19]. The contralateral orbit may also be affected due to reflux of blood across the circular sinus, occasionally in the absence of ipsilateral orbital symptoms depending on the pattern of venous drainage [1, 9, 12]. Other signs and symptoms of orbito-ocular congestion include medically refractory glaucoma, ophthalmoplegia, retro-orbital pain, vision loss, as well as dilatation and arterialization of conjunctival and episcleral veins on ophthalmologic exam [1, 12]. Although this latter finding may be seen in the setting of other diseases such as conjunctivitis, a tortuous corkscrew appearance of these vessels is highly specific for the diagnosis of CCF [12]. General differential considerations for physical exam findings suggestive of orbito-ocular congestion include vascular malformations involving the orbit or cavernous sinus, cavernous sinus thrombosis, as well as inflammatory processes such as scleritis, with vortex vein blockage [1].
Some CCFs may present without classic symptoms, depending on the pattern of venous drainage as well as the degree of arteriovenous shunting [3, 11, 15, 18, 28]. For example, low-flow indirect CCFs with exclusively posterior venous drainage characteristically lack signs and symptoms of orbito-ocular congestion, including pulsatile exophthalmos and orbital bruit [3, 4, 12, 29, 30]. Instead, these lesions often are either asymptomatic or associated with nonspecific symptoms including headache, tinnitus, trigeminal neuropathy, facial nerve palsy, or isolated oculomotor palsy due to the involvement of the corresponding cranial nerves [11, 12, 30]. In these instances, patient symptoms may be due, at least in part, to brainstem congestion resulting from the posterior venous drainage [12, 31]. The atypical presentation of these posteriorly draining fistulas often leads to a delay in their diagnosis, which is unfortunate given the association between drainage via the superior petrosal sinus and cortical venous reflux, a high-risk feature discussed subsequently in this chapter [1, 4].
Clinical Presentation of Carotid Cavernous Fistulas
-
Fistulas with anterior drainage via orbital veins
-
Pulsatile exophthalmos
-
Chemosis
-
Glaucoma
-
Vision loss
-
Ophthalmoplegia
-
-
Fistulas with exclusively posterior drainage via petrosal sinuses
-
Asymptomatic
-
Headache
-
Tinnitus
-
Trigeminal neuropathy
-
Isolated oculomotor palsy
-
Finally, symptom progression in CCFs is often determined by the degree of associated arteriovenous shunting, with high-flow lesions often presenting acutely with rapid deterioration, while low-flow fistulas may demonstrate an insidious onset and subsequent benign course [1, 15]. Low-flow shunts are most often encountered in the setting of an indirect, dural CCF, although direct lesions may also behave in a similar manner if the tear in the cavernous ICA is relatively small or if there is partial thrombosis of the involved cavernous sinus [1]. Recurrent fistulas following treatment may also present insidiously, again depending on the amount of residual arteriovenous shunting and available venous drainage pathways [22].
7 Complications and High-Risk Features
Ophthalmologic complications of CCFs include vision loss, ophthalmoplegia, and medically refractory glaucoma [1, 12]. Ophthalmoplegia can result from either entrapment of the extraocular muscles due to swelling of these structures or due to cranial nerve palsy secondary to mechanical compression of the corresponding nerve(s) [1, 12]. Glaucoma in CCFs may develop from high orbital venous pressure, congestion of the choroid or iris, displacement of the iris-lens diaphragm, or neovascularity secondary to chronic ischemia [12]. Finally, loss or deterioration of vision in the involved eye can be secondary to venous stasis retinopathy with resulting retinal ischemia, secondary glaucoma with optic nerve damage, or spontaneous choroidal detachment [1, 11, 12]. Vision loss is more commonly seen with direct CCF, although this finding may be encountered in as many as 20–30 % of indirect fistulas, particularly chronic lesions [12].
Ophthalmologic Complications of Carotid Cavernous Fistulas
-
Glaucoma
-
Elevated orbital venous pressure
-
Choroid or iris congestion
-
Iris-lens diaphragm displacement
-
Neovascularity
-
-
Ophthalmoplegia
-
Extraocular muscle swelling
-
Cranial nerve palsy
-
-
Vision loss
-
Venous stasis retinopathy
-
Glaucoma with optic nerve damage
-
Spontaneous choroidal detachment
-
Additional complications of CCFs include intracranial hemorrhage, both intraparenchymal and subarachnoid, venous infarct, epistaxis (which may be fatal), as well as increased intracranial pressure with venous hypertension [18, 26, 32]. Intraparenchymal hemorrhage is often a result of reflux of high-pressure arterialized blood into cortical veins overlying adjacent brain parenchyma [1, 15, 18]. Posterior venous drainage of a CCF via the superior petrosal sinus has been associated with the development of this high-risk feature and may be precipitated by the spontaneous thrombosis or iatrogenic occlusion of alternative venous drainage pathways [1, 4, 15, 18]. Overall, cortical venous reflux has been reported in anywhere from 10 % to 55 % of CCFs, is often symptomatic due to increased intracranial pressure, and carries up to a 30–40 % chance of hemorrhagic stroke if untreated [15, 18, 26, 33]. Furthermore, the reported annual mortality rate of intracranial dural arteriovenous fistulas with cortical venous reflux, regardless of location, is 10.4 % [33].
Subarachnoid hemorrhage from a CCF has been associated with the development of a cavernous sinus varix or pseudoaneurysm (Fig. 7) [18]. In a retrospective review of the angiographic features of 155 patients with CCFs, Halbach et al. [18] found that cavernous sinus venous varix was present in three of four patients who presented with subarachnoid hemorrhage, all of which were fatal. Although cavernous sinus varices were encountered in patients without intracranial hemorrhage, the authors argued the risk of fatal subarachnoid hemorrhage warranted emergent fistula treatment with this finding is present [18]. Finally, drainage into the sigmoid and transverse sinuses has been associated with elevation of intracranial pressure from resulting venous hypertension [18].
High-Risk Features of Carotid Cavernous Fistulas
-
Cortical venous reflux
-
Between 10 % and 55 % of CCFs
-
Up to 30–40 % risk of hemorrhagic stroke untreated
-
Associated with superior petrosal sinus drainage
-
Can arise from blockage of venous drainage pathways
-
-
Subarachnoid hemorrhage
-
Rare, but often fatal
-
Associated with cavernous sinus varix
-
-
Drainage into sigmoid and transverse sinuses
-
Risk of elevated intracranial pressure from resulting venous hypertension
-
8 Imaging Evaluation
Noninvasive Cross-Sectional Imaging: Although many patients with a CCF present with classic signs and symptoms suggestive of the diagnosis, others may demonstrate either atypical symptomatology and/or an insidious, slowly progressive course [26]. In these instances, conventional MR, time-of-flight (TOF) and contrast-enhanced MR angiography (MRA), Doppler ultrasound, as well as CT angiography (CTA), may be used to screen patients for the presence of an arteriovenous fistula involving the cavernous sinus [34–36]. Conventional MR imaging finding suggestive of a CCF includes prominent flow voids in the involved cavernous or inferior petrosal sinuses on spin-echo sequences, dilated intercavernous venous channels, as well as the sequelae of orbito-ocular congestion including enlargement of the superior ophthalmic vein and extraocular muscles and proptosis [37–39]. However, these findings may only be present in high-flow fistulas, with conventional MR imaging being relatively insensitive for lesions demonstrating less rapid arteriovenous shunting [40].
3D TOF MRA can increase the sensitivity for detection of CCF by depicting flow-related enhancement in the involved cavernous sinus as well as arterial feeders in the setting of an indirect fistula [35, 37, 40]. It is important to note however that venous flow signal can be normally seen in the cavernous and inferior petrosal sinuses on 3D TOF MRA in the absence of a CCF [41]. In addition, 3D TOF MRA is limited by the lack of temporal resolution, which precludes full characterization of dynamic shunting lesions such as a CCF [40]. However, time-resolved contrast-enhanced MRA can help to overcome some of these challenges by imaging the suspected diseased cavernous sinus during passage of a gadolinium contrast bolus [40]. This technique has been shown to be both sensitive and specific for the diagnosis of CCF and is a promising tool both for screening patients as well as surveillance for fistula recurrence following treatment (Fig. 8) [40].
CT angiography has also been demonstrated to be a promising technique for screening patients suspected of having a CCF [42]. With the availability of 256 and 320 slice CT scanners, excellent quality dynamic studies can be performed with high spatial and acceptable temporal resolution. CT and CT angiography findings of a CCF include an enlarged cavernous sinus that demonstrates early enhancement in the arterial phase, as well as dilatation of draining venous tributaries (e.g., superior ophthalmic vein) [42, 43]. Chen et al. [37] performed a retrospective study comparing noninvasive 3D TOF MRA and CTA to the gold standard of catheter angiography. They found that CTA performed better at detecting CCF than TOF MRA, particularly for fistula involving the more proximal aspect of the cavernous ICA (Table 2).
Catheter Angiography: Despite advances in cross-sectional imaging of CCF, catheter angiography remains the gold standard for the diagnosis and characterization of these lesions due to its superior spatial and temporal resolution [26, 40]. The diagnosis of a CCF is readily made on catheter angiography by the demonstration of abnormal arteriovenous shunting into the cavernous sinus from either the ipsilateral cavernous ICA or meningeal branches to the sinus wall in the case of an indirect fistula. Goals of catheter angiography when evaluating a CCF include the identification of the exact site of fistulization, evaluation of the degree of arteriovenous shunting, determination of arterial supply to the lesion, evaluation of the pattern of venous outflow, the presence of high-risk features including cortical venous reflux and venous varix, potential dangerous external or internal carotid artery anastomoses, as well as the presence of atherosclerotic disease if carotid compression is contemplated as a potential treatment [26].
Catheter Angiography Evaluation of Carotid Cavernous Fistulas
-
Determination of type of fistula
-
Arterial supply with indirect lesions
-
Localization of fistulous tear with direct lesions
-
Evaluation of degree of arteriovenous shunting
-
Analysis of venous drainage pathways
-
Identification of high-risk features, including cortical venous reflux
Huber’s Maneuver: In the setting of a high-flow CCF, the tremendous arteriovenous shunting may obscure the underlying ICA tear, and the carotid artery more distally may not fill due to essentially complete diversion of blood flow into the cavernous sinus [2, 10, 22]. In these instances, injection of a vertebral artery during manual compression of the ipsilateral ICA may allow for better characterization of both the location and the size of the fistulous communication (Fig. 9) [10, 44]. This technique works by allowing a limited amount of contrast to reach the shunt via a posterior communicating artery with subsequent retrograde flow down the ipsilateral supraclinoid ICA [10]. Other maneuvers that can help delineate the fistula size and location include very high frame rate imaging and 3D subtraction angiography. Finally, C-arm angiographic CT (flat panel rotational computed tomography) is another exceptional technique for locating and studying the anatomy of fistula.
Balloon Occlusion Test (BOT): As a significant minority of direct CCFs may require ipsilateral ICA sacrifice for successful closure, performing a balloon occlusion test during the diagnostic workup can provide invaluable information to the treating physician (Fig. 10). First, a guide catheter is placed in the ipsilateral common carotid artery. Next, following full heparinization, a soft, compliant balloon (typically a HyperForm or HyperGlide Occlusion Balloon, ev3, Irvine, California) is navigated into the cervical ICA proximal to the fistula. The balloon is then carefully inflated under fluoroscopic imaging, and a gentle injection is performed through the guide catheter to confirm vessel occlusion. Continuous neurologic monitoring, including testing of patient speech and contralateral strength, is then performed for a total of 30 min. The test is immediately stopped if the patient develops symptoms suggestive of ischemia involving the ipsilateral cerebral hemisphere. The patient can be further challenged during a balloon occlusion test by purposefully dropping the systolic blood pressure by 30 %, although all operators do not routinely perform this maneuver. Finally, collateral flow to the affected vascular territory via the Circle of Willis (i.e., an angiographic balloon occlusion test) can be performed during balloon inflation by injection of the contralateral carotid and vertebral arteries using a second diagnostic catheter.
9 Management
The management of CCFs is often determined by multiple interdependent factors, including the rate of arteriovenous shunting, the venous pathways recruited by the fistula, the degree of associated orbito-ocular congestion, as well as the presence of cortical venous reflux or venous varix [15, 45]. Treatment options include conservative management with close imaging follow-up as well as endovascular or surgical repair. Indications for aggressive fistula treatment include progressive vision loss, cranial nerve palsies, rapidly worsening proptosis with corneal exposure, cortical venous reflux, and intractable retro-orbital pain [14, 19]. It is important to note that these signs and symptoms may be reversible only when treatment is initiated early in the course of the disease, emphasizing the importance of prompt diagnosis and prompt treatment [1, 27, 46]. Liang et al. [16] found in their retrospective review of post-traumatic direct CCFs that the time from first symptom onset to treatment was significantly shorter in patients who had no fistula-related disability on follow-up compared to those who did (41.5 days compared to 140.8 days). Finally, although complete fistula cure is often attempted, partial occlusion/embolization may be adequate if it addresses either intolerable symptomatology or high-risk features such as cortical venous reflux.
The following sections further explore the various management options available to patients with CCFs.
9.1 Conservative Management
When discussing possible treatment of a CCF with a patient, the potential risks and benefits of therapy should be weighed against the natural history of the patient’s particular lesion [18, 26]. Spontaneous closure of indirect CCF has been reported anywhere between 10 % and 73 % of cases, although spontaneous closure of direct fistulas is thought to be considerably more rare [9, 14, 18, 19, 26]. Interestingly, spontaneous fistula closure may be precipitated by catheter angiography [18, 19, 26]. Accordingly, low-flow fistulas without significant orbito-ocular congestion, high-risk angiographic features, or other intolerable symptoms can often be followed conservatively [1, 9, 15]. However, close clinical as well as periodic imaging follow-up is required though to exclude the development of aggressive fistula features [1]. Stiebel-Kalish et al. [9] found in a retrospective review that clinical signs suggestive of the presence of cortical venous reflux in indirect CCF include bilateral orbital symptoms as well as the presence of a postauricular bruit. Patients with these features should undergo catheter angiography for further evaluation.
During this time, patients may help to promote fistula closure by manually compressing the ipsilateral cervical carotid artery and internal jugular vein several times a day (Fig. 11) [47, 48]. Higashida et al. [48] found that this resulted in cure of indirect CCF in 30 % of patients anywhere from several minutes to 6 months. This maneuver can even result in lesion closure in a minority of direct CCF (17 %). Kai et al. [49] found that factors associated with a higher likelihood of achieving fistula closure with manual compression for indirect lesions included a shorter time between symptom onset and initiation of treatment, lower ocular pressure, and venous drainage exclusively via the superior ophthalmic vein. Patients should be instructed to be sitting during the maneuver and to use the contralateral arm [49]. Otherwise, transient lack of blood flow to the ipsilateral cerebral hemisphere may lead to syncope as well as inadvertent prolonged compression if the ipsilateral arm is used (which would not be affected by the resulting ischemia).
Carotid Manual Compression of Carotid Cavernous Fistulas
-
Appropriate for low-flow lesions without high-risk features or progressive symptoms.
-
Patient should be sitting in case of syncope.
-
Patients should perform maneuver several times a day.
-
Patient should be instructed to use contralateral hand in case of ipsilateral cerebral ischemia.
9.2 General Considerations of Endovascular Treatment
A large majority of both direct and indirect CCFs can be successfully treated using modern endovascular techniques with a low rate of procedure-related complications [11, 50]. Embolization materials currently used for the treatment of CCFs include fiber and platinum microcoils, detachable latex balloons, as well as liquid embolic agents including n-butyl cyanoacrylate (nBCA) or ethylene vinyl alcohol (Onyx, ev3, Irvine, California) [50–52]. Transarterial, transvenous, as well as combined approaches may be utilized for fistula closure (Fig. 12) [11, 50, 53]. The endovascular method used to treat a given lesion often is determined by multiple factors, including the type of shunt (direct vs. indirect), the size of the ICA tear with direct fistulas, the rate of arteriovenous shunting, as well as the accessibility of venous pathways to the involved cavernous sinus [15].
General risks of endovascular treatment of CCFs include stoke, hemorrhage, vessel injury, and parent artery occlusion. In addition, patients should be counseled that their symptoms may temporarily, or rarely permanently, worsen following therapy as the fistula thromboses, with alterations of venous drainage [15]. Obtaining a complete diagnostic catheter angiogram prior to embolization is essential to define important fistula characteristics such as arterial supply and venous drainage, as well as to evaluate for high-risk features including cortical venous reflux [45]. In addition, the interventionalist must pay close attention to alterations of venous drainage from the cavernous sinus during embolization of a CCF. Inadvertent diversion of blood into the sphenoparietal or superior petrosal sinuses after partial fistula embolization may lead to cortical venous reflux and hemorrhagic stroke [15, 26, 45, 54, 55]. Similarly, redirection of venous drainage anteriorly into the ipsilateral orbit can lead to worsening of orbito-ocular congestion, with possible resulting loss of vision [28, 55]. Finally, patients should be advised that some symptoms, particularly cranial nerve palsies, may not improve despite successful fistula closure [46].
Endovascular Treatment of Carotid Cavernous Fistulas
-
Materials
-
Detachable Balloons
-
Platinum or fiber coils
-
Liquid embolic agents
-
n-Butyl cyanoacrylate (nBCA, glue)
-
Ethylene vinyl alcohol copolymer (Onyx)
-
-
Covered Stents
-
-
Endovascular Access
-
Ipsilateral carotid artery for direct fistula
-
Venous routes
-
Inferior petrosal sinus
-
Facial and angular veins
-
Pterygoid venous plexus
-
Superior petrosal sinus
-
Percutaneous puncture of superior ophthalmic vein
-
-
Transarterial catheterization of meningeal feeders of indirect fistulas
-
9.3 Endovascular Treatment of Direct CCF
Detachable Balloons: The goal of endovascular treatment of direct CCF is complete fistula closure with preservation of the ICA [14, 56]. Early endovascular approaches to direct CCF consisted of transarterially navigating a catheter with a detachable balloon mounted at its tip past the tear in the cavernous ICA and into the cavernous sinus. Once in position, one or more of these balloons were sequentially inflated and detached in the cavernous sinus to achieve fistula closure [12, 22, 33, 53]. Detachable balloons used for CCF treatment are made of latex and inflated with contrast medium in position [19]. Serbinenko [57] was the first to use such an approach for the treatment of CCFs, followed by Debrun et al. [58]. This method is very successful at achieving fistula closure, with high rates of ICA preservation and low procedure-related morbidity and mortality [10, 11, 14, 59]. Lewis et al. [14] demonstrated an 88 % rate of complete occlusion of direct CCF via the transarterial balloon embolization method, with a 75 % rate of ICA preservation. The permanent neurologic complication rate was only 4 %.
Challenges to transarterial balloon embolization of direct CCFs include difficulties navigating the relatively stiff balloon catheters, inability to cannulate small ICA tears, inability to inflate a balloon in small-sized venous compartments with the cavernous sinus, balloon compression and compromise of the cavernous ICA or cranial nerves, as well as subsequent balloon deflation or migration [10, 14, 55, 56, 59, 60]. Balloon deflation or migration could result in fistula recurrence, the development of an ICA pseudoaneurysm, or compression of the ICA and cranial nerves [14, 56, 60]. In addition, some patients following detachable balloon treatment have developed recanalization of a true cavernous ICA aneurysm, which was presumably responsible for development of the fistula [60]. Transarterial balloon embolization of direct CCFs has been abandoned in the USA due to the lack of commercially available detachable balloons.
Coils and Liquid Embolic Agents: An alternative endovascular treatment of direct CCFs is the placement of coils into the involved cavernous sinus via a transarterial approach [11, 19, 55]. Once the microcatheter is in position in the sinus, multiple fiber or platinum microcoils can be carefully deployed in the venous sinusoids closest to the point of arteriovenous fistulization [55]. Similar, to detachable balloons, challenges to coil embolization include difficulties navigating the microcatheter into the cavernous sinus if the ICA tear is small, as well as inadvertent coil prolapse into the ICA with larger rents [52, 55]. The latter may be particularly difficult to visualize in the setting of a high-flow shunt and can result in parent vessel occlusion and/or stroke. The risk of coil prolapse into the ICA may be mitigated by placement of an endovascular stent and/or non-detachable balloon in the vessel prior to embolization [13, 52]. Finally, it is possible to occlude a large majority of the diseased cavernous sinus with coils and still have residual arteriovenous shunting if the portion of the sinus closest to the fistula remains patent [50].
Embolization of a direct CCF may be supplemented or replaced by liquid embolic agents such as nBCA or ethylene vinyl alcohol (Onyx) [56, 61]. The non-adhesive nature of Onyx offers several advantages over nBCA, including the reduced risk of microcatheter retention, which allows for longer injection times and more thorough penetration of the liquid embolic agent into the lesion [50]. Potential risks of liquid embolic embolization of direct CCF include nontarget embolization of the ipsilateral ICA and its branches as well as cranial neuropathy. The risk of reflux of liquid embolic agent may be mitigated by inflation of a balloon into the ipsilateral cavernous ICA during liquid embolic injection [62].
Alternative Routes to the Cavernous Sinus: If a transarterial approach is either not technically possible or fails to adequately close a direct CCF, transvenous treatment may be attempted [54]. A transvenous approach can be performed by placement of a guide catheter in the ipsilateral internal jugular vein followed by navigation of a microcatheter into the cavernous sinus via the inferior petrosal sinus [45, 53, 54]. However, it is not always possible to access the cavernous sinus via this route due to either thrombosis or stenosis of the inferior petrosal sinus [15, 53, 63]. In these instances, alternative routes to the cavernous sinus include the ipsilateral facial and angular veins, the contralateral pterygoid venous plexus, as well as the superior petrosal sinus via the transverse sinus [15, 29, 53, 63].
On occasion, it may only be possible to reach the involved cavernous sinus from a transvenous approach via direct surgical cannulation/percutaneous puncture of the ipsilateral superior ophthalmic vein [27, 28]. This method has been shown to be both safe and effective, with cannulation of the vein possible even if it appears thrombosed on imaging [27]. Once microcatheter access to the cavernous sinus has been achieved, embolization can then proceed with coils and/or liquid embolic agents [61]. Potential complications of direct puncture of the superior ophthalmic vein include rupture of the vessel with retroocular hemorrhage and rapid visual loss, infection, and damage to other orbital structures [28]. Finally, there are a few report of direct percutaneous cannulation of the inferior ophthalmic vein performed for fistula treatment [64].
Internal Carotid Artery Sacrifice: If other endovascular methods of closing a direct CCF fail, ICA sacrifice should be considered (Fig. 13) [56]. The latter technique has proven to be highly successful in the treatment of direct CCFs, although there is a risk of ipsilateral cerebral hemispheric stroke. This risk may be mitigated, in part, by performing a balloon occlusion test prior to artery closure. However, a successful balloon occlusion test does not guarantee a good outcome. High-flow direct CCFs that demonstrate complete diversion of blood into the lesion with non-opacification of the supraclinoid ICA represent a special circumstance when carotid artery sacrifice should be considered [60]. If the patient has not suffered from stroke or TIA-like symptoms, the hemodynamics of the fistula provide strong evidence that carotid occlusion will be tolerated. On the other hand, as many of these patients are relatively young, carotid artery sacrifice must be weighed against the risk of the patient developing stenosis or occlusion of another major artery in the head and neck later in life.
Covered Stents: Covered stents have also been used to treat direct CCFs, either alone or in combination with coils and liquid embolic agents (Fig. 14) [51, 65, 66]. Gomez et al. [51] treated seven patients with post-traumatic CCFs with polytetrafluoroethylene (PTFE)-covered stents, all of which had successful fistula closure and no immediate procedure-related morbidity or mortality. However, one patient subsequently developed asymptomatic in-stent occlusion [51]. Tiewei et al. [65] reported similarly good results in a group of eight patients with traumatic direct CCF treated with covered coronary stents. Five of the eight patients had occlusion of their fistula following stent placement, while six went on to have resolution of their symptoms. However, once again, there was one case of subsequent asymptomatic in-stent occlusion [65]. Another group, Wang et al. [66], reported successful closure of 8 out of 10 direct CCF that failed more conventional endovascular therapy, with no in-stent stenosis or occlusion during the follow-up period of the study. These results suggest that covered stents are a promising new endovascular treatment of direct CCFs. However, more data is needed, particularly in regard to the long-term patency of these devices. Finally, as is the case with other endovascular stents, patients must be maintained on dual antiplatelet therapy for at least 3 months following treatment [51]. This is a significant drawback to treatment with covered stents, particularly in patients who recently experienced significant head trauma (Table 3).
9.4 Endovascular Treatment of Indirect or Dural CCF
Transvenous embolization of indirect, dural CCF is a safe and efficacious treatment for patients who have progressive symptoms and high-risks features on imaging or who fail conservative management (Fig. 15) [15, 28, 45, 50, 63, 67]. Similar to all intracranial dural arteriovenous fistulas, the goal of therapy is closure of the arteriovenous shunts connecting meningeal arteries to feeding veins [45]. For indirect CCF, this has been most commonly accomplished by placement of multiple coils in the diseased cavernous sinus [45, 50]. Kirsch et al. [46] reported either complete lesion closure or minor residual shunt without cortical or ocular drainage in 94 % of 141 patients treated using this approach. Meyers et al. [26] reported similar results with 90 % of patients cured following transvenous embolization of indirect CCF in a retrospective review of 135 patients.
However, transvenous coil embolization of indirect CCF may not always be successful due to the trabeculated structure of the cavernous sinus, which can preclude adequate coil placement in the venous compartment(s) involved by the shunt [45, 50]. In these instances, embolization may be successfully performed using liquid embolic agents, either alone or in combination with coils (Fig. 16) [45, 67, 68]. Furthermore, if a transvenous approach to an indirect CCF is not possible due to either venous stenosis or occlusion, a transarterial approach with a liquid embolic agent may also be utilized [50]. Onyx, with its ability to penetrate small arterial feeders during prolonged injections, is uniquely well suited to reach the small dural shunts from an arterial pedicle [50]. Care must be taken however as retrograde filling of non-catheterized arterial pedicles is possible with Onyx, which may lead to nontarget embolization of the arterial supply to the brain, eye, or other cranial nerves. Finally, other treatment options for indirect CCF include transarterial embolization using a particulate agent such as polyvinyl alcohol (PVA) (Fig. 17) [69]. A major limitation of this latter approach however is a high rate of fistula recurrence, which is less likely following embolization using coils or liquid embolic agents [69] (Table 4).
9.5 Surgical Treatment
Prior to the advent of modern endovascular techniques, surgical closure of CCFs was the standard of care [11]. Early surgical treatment for these lesions consisted primarily of carotid artery sacrifice by vessel trapping [10, 11, 70]. Parkinson [71] subsequently developed a direct surgical approach to the cavernous sinus via a triangular space in the lateral sinus wall demarcated by the III and IV cranial nerves superiorly and the V and VI cranial nerves inferiorly. With the aid of circulatory arrest and induced hypothermia, he went on to use this approach to treat both direct and indirect CCF, often preserving the carotid artery [72]. Modern surgical treatment of CCFs consists of a combined extradural-intradural approach to the cavernous sinus, with disconnection of arterial feeders in the case of indirect fistulas and clipping or suture repair of fistulous rents in the case of direct lesions [73, 74]. In addition, both direct and indirect fistulas may be indirectly occluded by packing the cavernous sinus with various materials, including muscle, glue, thrombus, and wires [18, 73, 74]. Due to the associated morbidity and technical challenges of surgical repair of CCFs, as well as the success of endovascular approaches, these procedures are most often performed only after failure of endovascular treatment [64].
9.6 Stereotactic Radiotherapy
Several small case series have demonstrated the efficacy of stereotactic radiosurgery for the treatment of indirect, low-flow CCFs without high-risk features [75–77]. Successful closure of the arteriovenous shunt has been reported between 12 and 36 months following treatment [1]. Onizuka et al. [76] reported their results of a small case series consisting of four elderly women with symptomatic indirect CCF who received stereotactic radiosurgery targeted to the compartment of the involved cavernous sinus with a marginal dose of 13–15 Gy and a maximum dose of 36–30 Gy. All four fistulas were successfully closed, and patients experienced symptom relief in 1–3 months. There were no instances of lesion recurrence or adverse events from treatment during the follow-up period [76]. Pollock et al. [77] reported similarly high rates of symptom improvement and fistula closure in 20 patients with indirect CCF (95 % and 93 %, respectively). However, stereotactic radiotherapy was supplemented by transarterial particulate embolization in 13 of these patients [77].
10 Conclusion
Carotid cavernous fistulas are complex lesions that can be challenging to diagnose and manage. A multidisciplinary approach, including neurointerventionalists, neurosurgeons, and ophthalmologists, is often required to achieve the best outcomes for patients. The benefits as well as the risks of treatment need to be carefully weighed against the natural history of these lesions, particularly low-flow, indirect fistulas. Finally, identification of high-risk features on catheter angiography, including cortical venous reflux and cavernous sinus venous varix, is essential to appropriately triage these patients.
References
De Keizer R (2003) Carotid-cavernous and orbital arteriovenous fistulas: ocular features, diagnostic and hemodynamic considerations in relation to visual impairment and morbidity. Orbit 22:121–142
Peeters FL, Kroger R (1979) Dural and direct cavernous sinus fistulas. AJR Am J Roentgenol 132:599–606
Kurata A, Takano M, Tokiwa K et al (1993) Spontaneous carotid cavernous fistula presenting only with cranial nerve palsies. AJNR Am J Neuroradiol 14:1097–1101
Stiebel-Kalish H, Setton A, Nimii Y et al (2002) Cavernous sinus dural arteriovenous malformations: patterns of venous drainage are related to clinical signs and symptoms. Ophthalmology 109:1685–1691
Barrow DL, Spector RH, Braun IF et al (1985) Classification and treatment of spontaneous carotid-cavernous sinus fistulas. J Neurosurg 62:248–256
Harris FS, Rhoton AL (1976) Anatomy of the cavernous sinus. A microsurgical study. J Neurosurg 45:169–180
Hashimoto M, Yokota A, Yamada H et al (2000) Development of the cavernous sinus in the fetal period: a morphological study. Neurol Med Chir 40:140–150
Ellis JA, Goldstein H, Connolly ES Jr et al (2012) Carotid-cavernous fistulas. Neurosurg Focus 32:E9
Stiebel-Kalish H, Setton A, Berenstein A et al (2002) Bilateral orbital signs predict cortical venous drainage in cavernous sinus dural AVMs. Neurology 58:1521–1524
Debrun G, Lacour P, Vinuela F et al (1981) Treatment of 54 traumatic carotid-cavernous fistulas. J Neurosurg 55:678–692
Barry RC, Wilkinson M, Ahmed RM et al (2011) Interventional treatment of carotid cavernous fistula. J Clin Neurosci Off J Neurosurg Soc Australas 18:1072–1079
Miller NR (2007) Diagnosis and management of dural carotid-cavernous sinus fistulas. Neurosurg Focus 23:E13
Gemmete JJ, Ansari SA, Gandhi D (2009) Endovascular treatment of carotid cavernous fistulas. Neuroimaging Clin N Am 19:241–255, Table of Contents
Lewis AI, Tomsick TA, Tew JM Jr (1995) Management of 100 consecutive direct carotid-cavernous fistulas: results of treatment with detachable balloons. Neurosurgery 36:239–244; discussion 244–235
Annesley-Williams DJ, Goddard AJ, Brennan RP et al (2001) Endovascular approach to treatment of indirect carotico-cavernous fistulae. Br J Neurosurg 15:228–233
Liang W, Xiaofeng Y, Weiguo L et al (2007) Traumatic carotid cavernous fistula accompanying basilar skull fracture: a study on the incidence of traumatic carotid cavernous fistula in the patients with basilar skull fracture and the prognostic analysis about traumatic carotid cavernous fistula. J Trauma 63:1014–1020; discussion 1020
Helmke K, Kruger O, Laas R (1994) The direct carotid cavernous fistula: a clinical, pathoanatomical, and physical study. Acta Neurochir 127:1–5
Halbach VV, Hieshima GB, Higashida RT et al (1987) Carotid cavernous fistulae: indications for urgent treatment. AJR Am J Roentgenol 149:587–593
Kobayashi N, Miyachi S, Negoro M et al (2003) Endovascular treatment strategy for direct carotid-cavernous fistulas resulting from rupture of intracavernous carotid aneurysms. AJNR Am J Neuroradiol 24:1789–1796
Gossman MD, Berlin AJ, Weinstein MA et al (1993) Spontaneous direct carotid-cavernous fistula in childhood. Ophthal Plast Reconstr Surg 9:62–65
Kupersmith MJ, Stiebel-Kalish H, Huna-Baron R et al (2002) Cavernous carotid aneurysms rarely cause subarachnoid hemorrhage or major neurologic morbidity. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc 11:9–14
Miller TR, Jindal G, Mohan S et al (2014) Diagnosis and management of trigemino-cavernous fistulas: case reports and review of the literature. J Neurointerv Surg 45:674–687
Hieshima GB, Cahan LD, Mehringer CM et al (1986) Spontaneous arteriovenous fistulas of cerebral vessels in association with fibromuscular dysplasia. Neurosurgery 18:454–458
Rios-Montenegro EN, Behrens MM, Hoyt WF (1972) Pseudoxanthoma elasticum. Association with bilateral carotid rete mirabile and unilateral carotid-cavernous sinus fistula. Arch Neurol 26:151–155
Schievink WI, Piepgras DG, Earnest FT et al (1991) Spontaneous carotid-cavernous fistulae in Ehlers-Danlos syndrome Type IV. Case report. J Neurosurg 74:991–998
Meyers PM, Halbach VV, Dowd CF et al (2002) Dural carotid cavernous fistula: definitive endovascular management and long-term follow-up. Am J Ophthalmol 134:85–92
Goldberg RA, Goldey SH, Duckwiler G et al (1996) Management of cavernous sinus-dural fistulas. Indications and techniques for primary embolization via the superior ophthalmic vein. Arch Ophthalmol 114:707–714
Quinones D, Duckwiler G, Gobin PY et al (1997) Embolization of dural cavernous fistulas via superior ophthalmic vein approach. AJNR Am J Neuroradiol 18:921–928
Klisch J, Huppertz HJ, Spetzger U et al (2003) Transvenous treatment of carotid cavernous and dural arteriovenous fistulae: results for 31 patients and review of the literature. Neurosurgery 53:836–856; discussion 856–837
Acierno MD, Trobe JD, Cornblath WT et al (1995) Painful oculomotor palsy caused by posterior-draining dural carotid cavernous fistulas. Arch Ophthalmol 113:1045–1049
Bussiere M, Lownie SP, Pelz DM et al (2009) Direct carotid-cavernous fistula causing brainstem venous congestion. J Neuro-Ophthalmol Off J N Am Neuro-Ophthalmol Soc 29:21–25
Turner DM, Vangilder JC, Mojtahedi S et al (1983) Spontaneous intracerebral hematoma in carotid-cavernous fistula. Report of three cases. J Neurosurg 59:680–686
Cognard C, Januel AC, Silva NA Jr et al (2008) Endovascular treatment of intracranial dural arteriovenous fistulas with cortical venous drainage: new management using Onyx. AJNR Am J Neuroradiol 29:235–241
Akiba H, Tamakawa M, Hyodoh H et al (2008) Assessment of dural arteriovenous fistulas of the cavernous sinuses on 3D dynamic MR angiography. AJNR Am J Neuroradiol 29:1652–1657
Chen JC, Tsuruda JS, Halbach VV (1992) Suspected dural arteriovenous fistula: results with screening MR angiography in seven patients. Radiology 183:265–271
Flaharty PM, Lieb WE, Sergott RC et al (1991) Color Doppler imaging. A new noninvasive technique to diagnose and monitor carotid cavernous sinus fistulas. Arch Ophthalmol 109:522–526
Chen CC, Chang PC, Shy CG et al (2005) CT angiography and MR angiography in the evaluation of carotid cavernous sinus fistula prior to embolization: a comparison of techniques. AJNR Am J Neuroradiol 26:2349–2356
Elster AD, Chen MY, Richardson DN et al (1991) Dilated intercavernous sinuses: an MR sign of carotid-cavernous and carotid-dural fistulas. AJNR Am J Neuroradiol 12:641–645
Hirabuki N, Miura T, Mitomo M et al (1988) MR imaging of dural arteriovenous malformations with ocular signs. Neuroradiology 30:390–394
Meckel S, Maier M, Ruiz DS et al (2007) MR angiography of dural arteriovenous fistulas: diagnosis and follow-up after treatment using a time-resolved 3D contrast-enhanced technique. AJNR Am J Neuroradiol 28:877–884
Ouanounou S, Tomsick TA, Heitsman C et al (1999) Cavernous sinus and inferior petrosal sinus flow signal on three-dimensional time-of-flight MR angiography. AJNR Am J Neuroradiol 20:1476–1481
Coskun O, Hamon M, Catroux G et al (2000) Carotid-cavernous fistulas: diagnosis with spiral CT angiography. AJNR Am J Neuroradiol 21:712–716
Ohtsuka K, Hashimoto M (1999) The results of serial dynamic enhanced computed tomography in patients with carotid-cavernous sinus fistulas. Jpn J Ophthalmol 43:559–564
Huber P (1976) A technical contribution of the exact angiographic localization of carotid cavernous fistulas. Neuroradiology 10:239–241
Wakhloo AK, Perlow A, Linfante I et al (2005) Transvenous n-butyl-cyanoacrylate infusion for complex dural carotid cavernous fistulas: technical considerations and clinical outcome. AJNR Am J Neuroradiol 26:1888–1897
Kirsch M, Henkes H, Liebig T et al (2006) Endovascular management of dural carotid-cavernous sinus fistulas in 141 patients. Neuroradiology 48:486–490
Halbach VV, Higashida RT, Hieshima GB et al (1987) Dural fistulas involving the cavernous sinus: results of treatment in 30 patients. Radiology 163:437–442
Higashida RT, Hieshima GB, Halbach VV et al (1986) Closure of carotid cavernous sinus fistulae by external compression of the carotid artery and jugular vein. Acta Radiol Suppl 369:580–583
Kai Y, Hamada J, Morioka M et al (2007) Treatment of cavernous sinus dural arteriovenous fistulae by external manual carotid compression. Neurosurgery 60:253–257; discussion 257–258
Gandhi D, Ansari SA, Cornblath WT (2009) Successful transarterial embolization of a Barrow type D dural carotid-cavernous fistula with ethylene vinyl alcohol copolymer (Onyx). J Neuro-Ophthalmol Off J N Am Neuro-Ophthalmol Soc 29:9–12
Gomez F, Escobar W, Gomez AM et al (2007) Treatment of carotid cavernous fistulas using covered stents: midterm results in seven patients. AJNR Am J Neuroradiol 28:1762–1768
Moron FE, Klucznik RP, Mawad ME et al (2005) Endovascular treatment of high-flow carotid cavernous fistulas by stent-assisted coil placement. AJNR Am J Neuroradiol 26:1399–1404
Biondi A, Milea D, Cognard C et al (2003) Cavernous sinus dural fistulae treated by transvenous approach through the facial vein: report of seven cases and review of the literature. AJNR Am J Neuroradiol 24:1240–1246
Halbach VV, Higashida RT, Hieshima GB et al (1988) Transvenous embolization of direct carotid cavernous fistulas. AJNR Am J Neuroradiol 9:741–747
Siniluoto T, Seppanen S, Kuurne T et al (1997) Transarterial embolization of a direct carotid cavernous fistula with Guglielmi detachable coils. AJNR Am J Neuroradiol 18:519–523
Luo CB, Teng MM, Chang FC et al (2006) Transarterial balloon-assisted n-butyl-2-cyanoacrylate embolization of direct carotid cavernous fistulas. AJNR Am J Neuroradiol 27:1535–1540
Serbinenko FA (1974) Balloon catheterization and occlusion of major cerebral vessels. J Neurosurg 41:125–145
Debrun G, Lacour P, Caron JP et al (1978) Detachable balloon and calibrated-leak balloon techniques in the treatment of cerebral vascular lesions. J Neurosurg 49:635–649
Norman D, Newton TH, Edwards MS et al (1983) Carotid-cavernous fistula: closure with detachable silicone balloons. Radiology 149:149–157
Marques MC, Caldas JG, Nalli DR et al (2010) Follow-up of endovascular treatment of direct carotid-cavernous fistulas. Neuroradiology 52:1127–1133
Goto K, Hieshima GB, Higashida RT et al (1986) Treatment of direct carotid cavernous sinus fistulae. Various therapeutic approaches and results in 148 cases. Acta Radiol Suppl 369:576–579
Zhao P, Liu L, Jiang C et al (2012) Coils and onyx embolization of traumatic carotid-cavernous fistula caused by an intradural internal carotid artery pseudoaneurysm. Neuroradiol J 25:231–236
Mounayer C, Piotin M, Spelle L et al (2002) Superior petrosal sinus catheterization for transvenous embolization of a dural carotid cavernous sinus fistula. AJNR Am J Neuroradiol 23:1153–1155
White JB, Layton KF, Evans AJ et al (2007) Transorbital puncture for the treatment of cavernous sinus dural arteriovenous fistulas. AJNR Am J Neuroradiol 28:1415–1417
Tiewei Q, Ali A, Shaolei G et al (2010) Carotid cavernous fistulas treated by endovascular covered stent grafts with follow-up results. Br J Neurosurg 24:435–440
Wang C, Xie X, You C et al (2009) Placement of covered stents for the treatment of direct carotid cavernous fistulas. AJNR Am J Neuroradiol 30:1342–1346
Arat A, Cekirge S, Saatci I et al (2004) Transvenous injection of Onyx for casting of the cavernous sinus for the treatment of a carotid-cavernous fistula. Neuroradiology 46:1012–1015
Suzuki S, Lee DW, Jahan R et al (2006) Transvenous treatment of spontaneous dural carotid-cavernous fistulas using a combination of detachable coils and Onyx. AJNR Am J Neuroradiol 27:1346–1349
Vinuela F, Fox AJ, Debrun GM et al (1984) Spontaneous carotid-cavernous fistulas: clinical, radiological, and therapeutic considerations. Experience with 20 cases. J Neurosurg 60:976–984
Vitek JJ, Smith MJ (2009) The myth of the Brooks method of embolization: a brief history of the endovascular treatment of carotid-cavernous sinus fistula. J Neurointerv Surg 1:108–111
Parkinson D (1967) Transcavernous repair of carotid cavernous fistula. Case report. J Neurosurg 26:420–424
Parkinson D (1973) Carotid cavernous fistula: direct repair with preservation of the carotid artery. Technical note. J Neurosurg 38:99–106
Day JD, Fukushima T (1997) Direct microsurgery of dural arteriovenous malformation type carotid-cavernous sinus fistulas: indications, technique, and results. Neurosurgery 41:1119–1124; discussion 1124–1116
Tu YK, Liu HM, Hu SC (1997) Direct surgery of carotid cavernous fistulae and dural arteriovenous malformations of the cavernous sinus. Neurosurgery 41:798–805; discussion 805–796
Barcia-Salorio JL, Soler F, Barcia JA et al (1994) Stereotactic radiosurgery for the treatment of low-flow carotid-cavernous fistulae: results in a series of 25 cases. Stereotact Funct Neurosurg 63:266–270
Onizuka M, Mori K, Takahashi N et al (2003) Gamma knife surgery for the treatment of spontaneous dural carotid-cavernous fistulas. Neurol Med Chir 43:477–482; discussion 482–473
Pollock BE, Nichols DA, Garrity JA et al (1999) Stereotactic radiosurgery and particulate embolization for cavernous sinus dural arteriovenous fistulae. Neurosurgery 45:459–466; discussion 466–457
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this entry
Cite this entry
Miller, T.R., Shivashankar, R., Jindal, G., Gandhi, D. (2016). Carotid Cavernous Fistula. In: Saba, L., Raz, E. (eds) Neurovascular Imaging. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9029-6_7
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9029-6_7
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9028-9
Online ISBN: 978-1-4614-9029-6
eBook Packages: MedicineReference Module Medicine